Crystal Pharmaceutical (SUZHOU) Co., Ltd.
USPTO PatentsView assignee record - 22 granted patents across 7 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Crystal ranks #13,373 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 7 technology areas.
- #13,373
- of 49,997 US assignees by volume
- 32nd percentile
- by Innovation Score (29.7/100)
- 12.4
- avg claims per patent
- +1900%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R13373 · Foreign Corporation #13,373 · 22 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 22 grants
- MID-PACK #13,373/49,997
- PHOTO-FINISH Canada Pipeline…
- CPC-NARROW A61P · 7 areas
- INNOV-THIN 29.7/100
- CLAIMS-RICH 12.4 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +1900% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Canada Pipeline Accessories Company, Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Crystal’s 29.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Crystal
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Crystal Pharmaceutic… · this assignee 30
Crystal Pharmaceutic… · this assignee
30 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Crystal's Innovation Score is 29.7/100 (32nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Crystal?
Each dot is one of Crystal’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Crystal’s own 12.4 claims/patent is at or below the 12.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Crystal's grants concentrate
Crystal Pharmaceutical (SUZHOU) Co., Ltd. is a focused PatentsView assignee: 7 CPC subclasses with 90.9% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (10 grants) versus a trough of 1 in 2019. By volume, Crystal sits between Constellium Singen GmbH and Carl Zeiss Vision GmbH.
Crystal's three-year grant acceleration
Crystal Pharmaceutical (SUZHOU) Co., Ltd. shows 5 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Crystal's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Constellium Singen
Constellium Singen GmbH
22 patents
- Cqlt Saargummi S…
Cqlt Saargummi Technologies S.À.R.L.
22 patents
- Cressi-sub S P A
Cressi-sub S.P.A.
22 patents
- Crypto LAB
Crypto LAB Inc.
22 patents
- Canada Pipeline A…
Canada Pipeline Accessories Company, Ltd.
22 patents
- Carbon Black
Carbon Black, Inc.
22 patents
- Cardiac Implants
Cardiac Implants LLC
22 patents
- Carl Zeiss Vision
Carl Zeiss Vision GmbH
22 patents
- Crystal Pharmaceu… ◀
Crystal Pharmaceutical (SUZHOU) Co., Ltd.
22 patents
What this shows Crystal holds 22 patents at rank #13,357, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Crystal
By rank, the assignees closest to #13,357 in granted patent volume.
- Constellium Singen GmbH #13,353 · 22 patents
- Cqlt Saargummi Technologies S.À.R.L. #13,354 · 22 patents
- Cressi-sub S.P.A. #13,355 · 22 patents
- Crypto LAB Inc. #13,356 · 22 patents
- Canada Pipeline Accessories Company, Ltd. #13,358 · 22 patents
- Carbon Black, Inc. #13,359 · 22 patents
- Cardiac Implants LLC #13,360 · 22 patents
- Carl Zeiss Vision GmbH #13,361 · 22 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Crystal's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Crystal's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
30 32nd percentile higher than 32% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 1 | 4.5% |
| 2020 | 10 | 45.5% |
| 2021 | 5 | 22.7% |
| 2022 | 1 | 4.5% |
| 2023 | 3 | 13.6% |
| 2024 | 1 | 4.5% |
| 2025partial year | 1 | 4.5% |
Which technologies does Crystal Pharmaceutical (SUZHOU) Co., Ltd. patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Crystal Pharmaceutical (SUZHOU) Co., Ltd.'s patent record in context - here's where to go next.
- Crystal Pharmaceutical (SUZHOU) Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 90.9% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #13,373 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Crystal Pharmaceutical (SUZHOU) Co., Ltd. against Constellium Singen GmbH, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 29.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.